Haemonetics 2nd Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Tesla acquires AI hardware company for up to $2 billion in stock
Haemonetics (HAE) PT Lowered to $80 at Jefferies
November 10, 2021 8:10 AM ESTJefferies analyst Anthony Petrone lowered the price target on Haemonetics (NYSE: HAE) to $80.00 (from $85.00) while maintaining a Buy rating.
The analyst commented, "Key updates from the call: 1) US plasma volumes improved to +20% (+14% last Q), 2) Nov volumes flat at +20% (high-end of revised... More
Haemonetics (HAE) Misses Q2 EPS by 1c, Lowers FY EPS Guidance
November 9, 2021 6:23 AM ESTHaemonetics (NYSE: HAE) reported Q2 EPS of $0.60, $0.01 worse than the analyst estimate of $0.61. Revenue for the quarter came in at $239.9 million versus the consensus estimate of $239.99 million.
GUIDANCE:
Haemonetics sees FY2022 EPS of $2.40-$2.65, versus the consensus of $2.76.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
... More